Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex (Q41889708)

13 October 2017

Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex (English)

1 reference

13 October 2017

3

Ascensao JL

0 references

author name string

Vaz F

series ordinal

1

1 reference

13 October 2017

Silva MR

series ordinal

2

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

British Journal of Cancer

13 October 2017

1 reference

13 October 2017

72

1 reference

13 October 2017

6

1 reference

13 October 2017

1498-1503

1 reference

Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Treatment of minimal residual disease in myeloid leukemia--the immunotherapeutic options with emphasis on Linomide

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Natural Cell-Mediated Immunity During Viral Infections

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Determining serotonin in whole human blood and that of laboratory animals

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Linomide, a new immunomodulatory drug, shows different effects on homologous versus heterologous collagen-induced arthritis in rats

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Regulation of the metastasis of murine ocular melanoma by natural killer cells.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine Coxsackievirus B3 myocarditis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Production of hematopoietic colony-stimulating factors by human natural killer cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Biology and clinical relevance of human natural killer cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

A murine model for B-cell lymphomagenesis in immunocompromised hosts: natural killer cells are an important component of host resistance to premalignant B-cell lines

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Effect of pharmacological purging on natural killer cell number and activity in human bone marrow.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplantation. A pilot study in patients with acute myeloid leukemia

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Treatment of minimal residual disease in acute leukemia--focus on immunotherapeutic options

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Natural killer cells: characteristics and regulation of activity

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Hematopoietic precursors resistant to treatment with 4-hydroperoxycyclophosphamide: requirement for an interaction with marrow stroma in addition to hematopoietic growth factors for maximal generation of colony-forming activity

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034089

Antiangiogenic effects of the quinoline-3-carboxamide linomide

18 August 2018

1 reference

12 December 2020

Autografting in chronic myelogenous leukemia followed by immunotherapy

1 reference

12 December 2020

Generation of human natural killer cells from pharmacologically purged bone marrow

1 reference

12 December 2020

Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma

1 reference

12 December 2020

Successful treatment of autoimmunity in MRL/1 mice with LS-2616, a new immunomodulator

1 reference

12 December 2020

Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice

1 reference

12 December 2020

Mechanism of action of the new immunomodulator LS2616 on T cell responses

1 reference

12 December 2020

A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells

1 reference

12 December 2020

Adherent lymphokine-activated killer cells in chronic myelogenous leukemia: a benign cell population with potent cytotoxic activity

1 reference

12 December 2020

Regulation of natural killer progenitors. Studies with a novel immunomodulator with distinct effects at the precursor level

1 reference

12 December 2020

Immune regulation of metastasis from in vivo derived syngeneic murine melanoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.536

1 reference

Dimensions Publication ID

13 October 2017

0 references

1 reference

13 October 2017

PubMed publication ID

8519666

1 reference